Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients: A Prospective Observational Study

NCT06952361 is registered in ClinicalTrials.gov with Ardak Arynov as lead sponsor.

NCT NCT06952361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06952361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients: A Prospective Observational Study
Lead sponsor
Ardak Arynov
Phase
Observational
Overall status
Completed
Start date
March 8, 2019
Completion date
November 24, 2021
Enrollment
107 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alternative physiological transfusion triggers, anemia, blood transfusion, cancer, hemoglobin